US 9533039
Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9533039 (Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K39/3955